PSA is the most commonly used biological marker for prostate cancer, but the result in this study showed that correlation between PSA level and patients' survival time was not significantly correlated (log-rank test, p = 0.246; Figure 3C). The gene discussed is KLK3; the disease is prostate carcinoma.